Zum Hauptinhalt springen

Benzodiazepine

09. November 2021 | Benzodiazepine

Benzodiazepine and Z-drug use and the risk of developing dementia.

Benzodiazepine and Z-drug use and the risk of developing dementia. Torres-Bondia F, Dakterzada F, Galván L, Buti M, Besanson G, Grill E, Buil R, de Batlle J, Piñol-Ripoll G. Int J Neuropsychopharmacol. 2021 Nov 2:pyab073. doi: 10.1093/ijnp/pyab073…

06. September 2021 | Benzodiazepine

The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity.

The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity. Catalani V, Botha M, Corkery JM, Guirguis A, Vento A, Scherbaum N, Schifano F. Pharmace…

06. September 2021 | Benzodiazepine

Assessing the clinical utility of the severity dependence scale for benzodiazepine use disorder.

Assessing the clinical utility of the severity dependence scale for benzodiazepine use disorder. Lowton K, Chiba G. S Afr J Psychiatr. 2021 Jul 28;27:1571. doi: 10.4102/sajpsychiatry.v27i0.1571. PMID: 34394974; PMCID: PMC8335755. http…

17. August 2021 | Benzodiazepine

Benzodiazepines and Amphetamines Use among Methadone Maintenance Participants and Their Associations with Treatment Adherence.

Benzodiazepines and Amphetamines Use among Methadone Maintenance Participants and Their Associations with Treatment Adherence. Cheng Z, Diao F, Chen GH, Lin CQ, Li L, Wu ZY, Cao XB. Biomed Environ Sci. 2021 Jun 20;34(6):499-502. doi: 10.3967…

24. Juli 2021 | Benzodiazepine

Mortality and concurrent use of opioids and hypnotics in older patients: A retrospective cohort study.

Mortality and concurrent use of opioids and hypnotics in older patients: A retrospective cohort study. Ray WA, Chung CP, Murray KT, Malow BA, Daugherty JR, Stein CM (2021) PLoS Med 18(7): e1003709. doi.org/10.1371/journal.pmed.1003709…

11. Juni 2021 | Benzodiazepine

EMCDDA. New report highlights public health risks and increasing availability of ‘designer benzodiazepines’ in Europe

EMCDDA. New report highlights public health risks and increasing availability of ‘designer benzodiazepines’ in Europe New benzodiazepines, which are not controlled by international drug laws, come under the spotlight today in a new report rel…

11. Juni 2021 | Benzodiazepine

EMCDDA. New benzodiazepines in Europe – a review

EMCDDA. New benzodiazepines in Europe – a review Summary This report provides a technical review of the current body of knowledge regarding new benzodiazepines that are monitored by the EU Early Warning System. The aims of this report are to stren…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten